Nanotechnology Drug Delivery Market Size Predicted to Hit USD 209.5 billion by 2032 at 9.1% CAGR, Says AMR

Allied Market Research published a report, titled, "Nanotechnology Drug Delivery Market by Formulation (Lipid-Based Nanomedicine, Polymer-Based Nanomedicine, Nanocrystals and Others), Applications (Oncology & Haematology, Infectious Diseases, Orthopaedics, Neurology, Urology, Immunology, and Others): Global Opportunity Analysis and Industry Forecast, 2022-2032". According to the report, the global nanotechnology Drug Delivery Industry generated $87.5 billion in 2022, and is anticipated to generate $209.5 billion by 2032, witnessing a CAGR of 9.1% from 2023 to 2032.

The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining competitive edge in the market.

𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐒𝐜𝐞𝐧𝐚𝐫𝐢𝐨-

• The COVID-19 outbreak had a moderate impact on the growth of the global nanotechnology drug delivery market.
• The travel restrictions disrupted the ongoing clinical trials and delayed the research and development of nanotechnology applications in healthcare, resulting in slowing the growth of the market.
• On the other hand, the urgent need for COVID-19 vaccine and treatment spurred rapid advancements in nanomedicine.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐨𝐧 𝐍𝐚𝐧𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝟐𝟎𝟑𝟐- 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡- https://www.alliedmarketresearch.com/request-sample/10824

Rise in prevalence of chronic diseases and advancement in nanotechnology drive the growth of the global nanotechnology drug delivery market. However, manufacturing complexities is hampering the nanotechnology drug delivery market growth. On the contrary, government initiatives in the field of nanotechnology drug delivery are expected to offer remunerative opportunities for expansion of the nanotechnology drug delivery market during the forecast period.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐨𝐟 𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐚𝐫𝐝𝐢𝐚𝐜 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 -

• Medtronic Inc.
• MAQUET GmbH & Co. KG
• Quest Medical, Inc.
• Angiodynamics, Inc.
• Terumo Cardiovascular Systems Corporation
• Edwards Life Science
• Abbott Vascular
• LivaNova PLC
• Boston Scientific Corporation
• Cook Medical

𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐚𝐫𝐝𝐢𝐚𝐜 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 -

Based on formulation, the polymer-based nanomedicine segment held the highest market share in 2022, accounting for more than one-third of the global nanotechnology drug delivery market, due to to high degree of versatility in terms of formulation design and drug delivery strategies. However, the lipid-based nanomedicine is projected to manifest the highest CAGR of 9.7% from 2023 to 2032, period owing to increase in interest for lipid based nanomedicine, and increase in number of FDA approval products.

Based on application, the oncology and haematology segment held the highest market share in 2022, accounting for nearly two-fifths global nanotechnology drug delivery market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to the high research and development activities towards the application of nanotechnology to effectively treat cancer. However, the neurology is projected to manifest the highest CAGR of 11.4% from 2023 to 2032, period due to ability of nanomedicines to effectively cross blood brain barrier and ensuring higher therapeutic effect.

Based on region, North America held the highest market share in terms of revenue in 2022, accounting for around two-fifths of the global nanotechnology drug delivery market revenue, owing to advancement in technology in nanomedicines and rise in prevalence of chronic disease such as cancer and strong presence of market key players. However, the Asia-Pacific region is expected to witness the fastest CAGR of 10.3% from 2023 to 2032 and is likely to dominate the market during the forecast period, owing to favorable government initiatives such as funding and presence of high-tech research institutes.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/10824

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.